Coulter, SmithKline agree to develop anti-B1 antibody.
D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000191:economics / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval; D006801:Humans; D007457:Iodine Radioisotopes; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D007457:Iodine Radioisotopes; C119496:tositumomab I-131